US FTC opposes Express Scripts, Caremark, Optum's request for injunction against PBM case
( December 19, 2024, 17:33 GMT | Official Statement) -- MLex Summary: Express Scripts, Caremark and Optum should be denied their request for a preliminary injunction against the US Federal Trade Commission’s administrative proceeding against them over insulin prices, the agency told a federal judge. The FTC argued it’s been established that administrative courts like its own may adjudicate public rights subject to review by a district court. Additionally, the pharmacy benefit managers fail to identify any prejudice flowing from removal protections for FTC commissioners and administrative law judges. See attached file. ...
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.